Akebia Therapeutics
AKBA
HK$15.01
Share price
0.52%
Change (1 day)
-14.35%
Change (1 year)
Categories
Operating Margin for Akebia Therapeutics (AKBA)
Operating Margin as of March 2025 (TTM): -43.33%
According to Akebia Therapeutics's latest financial reports and stock price the company's current Operating Margin is -43.33%. At the end of 2024 the company had an Operating Margin of -43.33%.
Operating Margin history for Akebia Therapeutics from 2017 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -43.33% | 62.42% |
| 2023 | -26.68% | -17.18% |
| 2022 | -32.22% | -75.82% |
| 2021 | -133.25% | 2.02% |
| 2020 | -130.61% | 52.84% |
| 2019 | -85.46% | 3.26% |
| 2018 | -82.76% | 103.58% |
| 2017 | -40.65% | -99.54% |
| 2016 | -8,843.45% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | 13.78% | -131.80% | 🇺🇸 USA |
 | 26.37% | -160.86% | 🇨🇭 Switzerland |
 | 18.78% | -143.34% | 🇺🇸 USA |
 | -121.10% | 179.48% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.